4X3A
 
 | |
4X37
 | |
4X38
 | |
4X39
 | |
4XFT
 | | Structure of IL-18 SER Mutant III | | Descriptor: | DIMETHYL SULFOXIDE, Interleukin-18 | | Authors: | Krumm, B.E, Meng, X, Xiang, Y, Deng, J. | | Deposit date: | 2014-12-29 | | Release date: | 2015-06-10 | | Last modified: | 2023-09-27 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Crystallization of interleukin-18 for structure-based inhibitor design.
Acta Crystallogr.,Sect.F, 71, 2015
|
|
4XFU
 | | Structure of IL-18 SER Mutant V | | Descriptor: | Interleukin-18 | | Authors: | Krumm, B.E, Meng, X, Xiang, Y, Deng, J. | | Deposit date: | 2014-12-29 | | Release date: | 2015-06-10 | | Last modified: | 2023-09-27 | | Method: | X-RAY DIFFRACTION (2.85 Å) | | Cite: | Crystallization of interleukin-18 for structure-based inhibitor design.
Acta Crystallogr.,Sect.F, 71, 2015
|
|
4XFS
 | | Structure of IL-18 SER Mutant I | | Descriptor: | DIMETHYL SULFOXIDE, GLYCEROL, Interleukin-18 | | Authors: | Krumm, B.E, Meng, X, Xiang, Y, Deng, J. | | Deposit date: | 2014-12-28 | | Release date: | 2015-06-10 | | Last modified: | 2023-09-27 | | Method: | X-RAY DIFFRACTION (1.91 Å) | | Cite: | Crystallization of interleukin-18 for structure-based inhibitor design.
Acta Crystallogr.,Sect.F, 71, 2015
|
|
2I1B
 | |
2ILA
 | |
2IRT
 | |
2KH2
 | | Solution structure of a scFv-IL-1B complex | | Descriptor: | Interleukin-1 beta, scFv | | Authors: | Wilkinson, I.C, Hall, C.J, Veverka, V, Muskett, F.W, Stephens, P.E, Taylor, R.J, Henry, A.J, Carr, M.D. | | Deposit date: | 2009-03-23 | | Release date: | 2009-09-08 | | Last modified: | 2022-03-16 | | Method: | SOLUTION NMR | | Cite: | High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.
J.Biol.Chem., 284, 2009
|
|
2KKI
 | |
2MIB
 | |
1J0S
 | | Solution structure of the human interleukin-18 | | Descriptor: | Interleukin-18 | | Authors: | Kato, Z, Jee, J, Shikano, H, Mishima, M, Ohki, I, Yoneda, T, Hara, T, Torigoe, K, Kondo, N, Shirakawa, M. | | Deposit date: | 2002-11-21 | | Release date: | 2003-11-11 | | Last modified: | 2023-12-27 | | Method: | SOLUTION NMR | | Cite: | The structure and binding mode of interleukin-18
Nat.Struct.Biol., 10, 2003
|
|
1ILT
 | |
1ILR
 | |
1IRP
 | |
1IOB
 | |
1L2H
 | | Crystal structure of Interleukin 1-beta F42W/W120F mutant | | Descriptor: | Interleukin 1-beta | | Authors: | Rudolph, M.G, Kelker, M.S, Schneider, T.R, Yeates, T.O, Oseroff, V, Heidary, D.K, Jennings, P.A, Wilson, I.A. | | Deposit date: | 2002-02-21 | | Release date: | 2003-02-04 | | Last modified: | 2024-02-14 | | Method: | X-RAY DIFFRACTION (1.54 Å) | | Cite: | Use of multiple anomalous dispersion to phase highly merohedrally twinned crystals of interleukin-1beta.
Acta Crystallogr.,Sect.D, 59, 2003
|
|
1MD6
 | | High resolution crystal structure of murine IL-1F5 reveals unique loop conformation for specificity | | Descriptor: | interleukin 1 family, member 5 (delta) | | Authors: | Pei, X.Y, Dunn, E.F, Gay, N.J, O'Neill, L.A. | | Deposit date: | 2002-08-07 | | Release date: | 2003-09-30 | | Last modified: | 2011-07-13 | | Method: | X-RAY DIFFRACTION (1.6 Å) | | Cite: | High-Resolution Structure of Murine Interleukin 1 Homologue IL-1F5 Reveals Unique Loop Conformations for Receptor Binding Specificity.
Biochemistry, 42, 2003
|
|
5R87
 | |
5R8L
 | |
5R8D
 | |
5R8I
 | |
5R8B
 | | PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2027049478 in complex with INTERLEUKIN-1 BETA | | Descriptor: | 5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole, Interleukin-1 beta, SULFATE ION | | Authors: | De Nicola, G.F, Nichols, C.E. | | Deposit date: | 2020-03-03 | | Release date: | 2020-04-22 | | Last modified: | 2024-03-06 | | Method: | X-RAY DIFFRACTION (1.49 Å) | | Cite: | Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein Inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes.
J.Med.Chem., 63, 2020
|
|
